Introduction
Those wh ç have devoted a long time to the treatment of leprosy are aware of the inadequacies of present day therapy. Even the drug most widely applied at the present time, namely dapsone, is still under research to find out the most efficient dose requirements, and the search for a more efficient drug continues_ Experiments of various combinations of drugs have been made, both using known as well as combinations of completely new drugs in the treatment of leprosy. In the present experiment the therapy applied is a combination of drugs composed of rifampicin and Isoprodian (L 73A). Rifampicin was applied for t h e first time in leprosy in 1965. Each tablet of Isoprodian used in this investigation contains a combination of 3 drugs, namely dapsone 50 mg, Isoniazid 250 mg and 250 mg Prothionamide.
Dapsone is the most widely applied dru � , Isoniazid is not a <;lrug to be 3Pplied routinely in leprosy.
Prothionamide is a drug appl { ed for the first time in leprosy in Indonesia_
MateriaIs and Methods
The experiment was carried out at the General Hospital in Jakarta (RSTM), subdivision for leprosy outpatient Department.
It was intended to treat at least 20 patients, ali male, and of the lepromatous type, wi th complete fo llow-up examination.
The reason why only male patients were chosen was the fa ct that thalidomide would be used in the event of lepra reaction. These patients were chosen carefully in order to minimize drop-outs, and considering the need fo r frequent fo llow-up examinations. Each new patient was given the following examinations :
(1) 10 ml of blood was drawn for examination of Hb , leucocyte count, BSR, differential count, thrombocyte count, SGOT and SGPT (2) A direct smear of the lesion for bacterioscopical examination (3) A skin biopsy for histopathological examination (4) A coloured photograph of the lesion Ali these examinations were done at the same day whenever possible. Follow-up examinations were undertaken mont111y to evaluate the clinicai progress, observe side-effects, and perform the same laboratory procedures as mentioned above. Treatment accompanied by 6 times fo llow-up would be completed in 6-7 months.
The treatment was started in September, 1973, by using rifampicin 2 x 300 mgjday and 3 x I tablet of L73A. Later on, treatment was modified to 2 x 300 mg rifampicin and 2 tablets of Isoprodian (I tablet of Isoprodian is equal to 2 tablets of L 73A used formeriy) with I day pause within each week, namely on Sunday. This quantity of drug was given in a single dose with breakfast. However, when the single dose treatment was difficult, patients were allowed to take the drug in divided doses. This dose was given to patients whose body weight was more than 40 kg, whereas patients weighing less than 40 kg were given half of the dose.
Results
This preliminary report relates to the results of the treatment of 13 male lepromatous patients at ages varying between lI and 65 years.
Eight patients have completed the 6 times fo llow-up. Five patients are under treatment for the duration of less than 6 times follow-up, specified as follows : Two patients have reached the 5th fo llow-up, 2 patients have reached the 4th fo llow-up and I patient has reached the 2nd follow-up.
It is hoped that all these patients will manage to complete the treatment in due time. Another 6 patients have just started treatment. Besides these patients there were 6 patients who have stopped the treatment in the early phases of treatment for the following reasons:
Two patients rejected the second biopsy, I patient because of the occurrence of a big keloid on the biopsy scar, I patient because of severe vomiting, restlessness and insomnia, whereas 2 patients have not returned for unknown reasons.
Clinicai ResuIts
The skin lesions found were in the form of erythematous macules of numular size, usually spread over the trunk, some times on the arms and thighs, diffuse infiltration and erythematous nodules usually found on the face, ear, extremities and sometimes on the trunk; and smaller nodular lesions of miliary and lenticular size, usually fo und on the ear, anel in I patient occurring on the lips, while in another patient fo und spreael over the back anel lim bs.
During the first weeks of treatment, improvement of the lesions was readily seen, especially the nodules and eliffuse infiltrations, whereas with noelular lesions of miliar anel lenticular size very slight or no improvement was observeel.
Macular lesions disappeared without leaving a mark. Diffu se infiltrateel lesions anel noelules partly disappeareel without leaving a mark, part1y leaving macules, partly leaving a wrinkleel skin the colour of which is normal or bluish.
In aeldition, there was also infiltration which unelerwent only a slight change either in terms of thickness or colouring.
Relating to this improvement, there was a elifference both inelivielually anel topographically. Relating to the changes in miliary and lenticular noduli, a slight improvement took place except in the erythema.
Infiltrates that took a long time to regress were those localized on the ear, face anel the elistal part of the ex tremities.
Notes on pa tients of in terest (I) A. L., age 65. After 6 follow-up examinations no trace of infiltration was to be seen on the skin, except that a few bu\1ae were always founel, appearing anel vanishing, containing c1ear or haemorrhagic fl uid mainly on the paim of the right hand, sometimes on the paim of the left hand anel on the sole of the infecteel fo ot. This lesion occurreel immeeliateJy before the treatment anel eluring the treatment.
(2) M. M., age 31. After 6 follow-up examinations persistent lesions remained in the form of noelules of miliary size in both ears, infiltration of the lower right leg with edema .. Persistent painful enlargement of the right femoral gland occurreel 3 months after the treatment. This patient appeared to suffer from active tuberculosis at the 5th follow-up, with the occurrence of haemoptosis. A sputum elirect smear examination showeel a nega tive result, while the result of culture is still awaited.
(3) W. A. , age 50. Before treatment there were lesions in the form of noelules spreael over the whole boely anel the existence of facies leonina. During the treatment a few lesions changed to become erosive, excoriative anel ulcerative after the 1st follow-up for a perioel of approximately 1 month at the 6th examination. Now, the lesions have become hyper-pigmented macules, wrinkleel anel encircled by sma\1 infiltrates which were somewhat erythematous.
(4) M. R., age 37. At the sixth monthly examination, the noduli of miliar and lenticular size on the back, breast, upper arm a n el neck persisto (5) Z. A., age 30. At the sixth monthly examination the lesions remained unchangeel in the fo rm of miliary noelules on the upper and lower \ip and on the nose. Bo th ears were irregularly thickeneel with shiny face due to the presence of a diffuse infiltrate of bluish colour. The fingers as we\1 as the skin covering the extensor part of the arm anel the lower thirel of the leg were also shiny and of a bluish colour.
(6) A. G., age 42. Prior to this trial he was treateel with Conteben for I Yz years, with Ciba 1906 during I Y2 years, with Lamprene for 15 months and with dapsone for I month, without any progresso After 5 months with this new method of treatment progress was quite satisfactory . It was seen objectively that the oeelema on the lower leg disappeared entirely and there was improvement in ali . infiltrations. The infiltration on the body disappeared fast leaving indistinct macules ; infiltration on the face became thinner although it took a little more time becoming pink coloured but ligh ter than the initial red colour.
(7) G. T., age 43 . Has completed 4 times follow-up. This patient underwent a gal lstone operation 1967 anel prior to this he was admitted to this hospital for 3 mon ths because of epigastric pain. During the first weeks of the treatment, he complained of nausea, but later on this complaint disappeared without special treatment. After the 3rd fo llow-up, the patient was suffering from a serious illness wi th high fe ver accompanied by vomiting and diarrhoea. The general condition go t worse, his weight elropped by 8 kg to 49 kg. During his serious illness, the lesions on the skin elid not increase although leprosy treatment was stopped for the time being.
Lepra Reaction
A mild leprosy reaction occurred in 3 patients but disappeared without special medication so that treatment could be continued without interruption. Details are as follows.
(1 ) A. A., age 60. From the 1st month onwards some nodules occurred but appeared and vanished, mainly on the extensor part of the arm , sometimes on the paim of the hand and on the lower leg.
(2) S. K., age li. At end of the 3rd month after having completed the 6th fol low-up, some nodules appeared on both underarms and on the extensor part of the leg as well as on the chest.
(3) S. L. , age 32. At the 1st fo llow-up, 3 new nodules were seen on the extensor part of the left arm and 2 appeared on the paim of the hand. They disappearyd slowly and no further new nodules occurred.
Side-effects
The side-effe cts found were nausea , vomiting, dizziness, weakness and insomnia, ali of which disappeared without special treatment, except that I dropped out because of severe vomiting as reported above.
Bacteriological Findings
Out of the 8 patients who have completed 6 months of follow-up, 3 patients were still bacteriologically positive, viz.: (I) Z. A., age 30, with several globi in the earlobes and solid forms of bacilli still present.
(2) M. T., age 30, with some globi in the earlobes. (3) S. K., age 11, still with solid bacilli at the 6th follow-up but no globus.
Other patients:
(4) M. M., age 31, negative for bacilli at the 6th follow-up (5) M. A., age 50, negative for bacilli at the 6th follow-up (6) A. L., age �5, negative for bacilli at the 6th follow-up (7) M. R., age 37, nega tive for bacilli at the .5th follow-up (8) W. A., age 53, negative for bacilli at the 3rd follow-up.
Eight pa tients who had not reached the 6th fo Jlow-up gave the fo Jlowing results :
(1) A. N. , age 60, nega tive for bacilli at the 4th fo Jlow-up (2) G. T., age 43 , negative for bacilli at the 5th follow-up (3) S. L. , age 32, negative for bacilli at the 4th fo Jlow-up (4) A. G., age 42, negative for baciJli at the 1st fo llow-up (5) A. B., age 31, negative for baciJli at the 1st fo Jlow-up.
Ali these 13 pa tients started with globi in their smears except the 2 last cases.
Histopathological Resuits
Histopathological examination during treatment revealed involution of leproma wi th reduction of the infiltration, bacilli became granular and fraomented and disappeared wi th the presence of fi brosis. The presence or absence of bacilli i� the histopathological specimens was in conformity with the smear results.
Laboratory J{esults
There are no significant changes in the haemoglobin, leucocyte count, differential count, thrombocyte, SGOT and SGPT during the treatment. The initial high value of ESR graduaJly decreased during treatment.
Discussion
Compared with the treatment with dapsone as "drug of choice", consisting of a maintenance dose of 350 mg per week in accordance with the regulation of the lOth lnternational Congress of Leprosy, the treatment which we are here describing could be regarded as a "bulldozer" treatment, considering the doses, combination of drugs and price.
Rifampicin 600 mg per day is a costly treatment involving a price which either cannot be paid by most of the patients, or only with difficulty. However, if the results are sa tisfactory, i t will still be worth-while.
The treatment of patients with the lepromatous type is considered by some to be a life-long treatment. We know that the lepromatous type is a contagious type . Life-long treatment and contagiousness are the two main fa ctors stimulating research wi th the "bulldozer" treatment with the aim of shortening the duration of treatment and hastening the process of conversion to the non-infectious conditions, while at the same time reducing emergence of lepra reaction and possibility of sequelae consisting of diverse fo rms of deformity.
Compared with other drugs this treatment is able to heal the lesions of nodular lesions of miliary and lenticular size and in the healing of the infiltration in the ear and the face it seemed that a longer time of treatment was needed.
A distinct healing with this drug was obtained with the patient A. G., 42 years old, who had been treated with other drugs approximately five years without success.
On the contrary there were 2 patients in whom globus, granularjfragmented as well as solid forms of Hansen's bacillus were still found.
Lepra reaction was slight so that treatment with a specific drug was not needed. Concerning side-effe cts such as nausea, vomiting and dizziness, such symptoms are understandable considering the high doses given once daily. The provisional conclusion of this research was that a longer time was needed to evaluate the efficiency of this kind of treatment.
